Medical University of Vienna - Akh

Vienna 1090

0 studies enrolling now · 2 studies all time

What they study most

IDH1-mutant Glioma, IDH2-mutant Glioma, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma — Running, not enrolling
• Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) — Running, not enrolling